Guangzhou Baiyunshan Pharma (0874.HK)
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a pharmaceutical company that specializes in researching, developing, manufacturing, and selling Chinese and Western medicines, along with other related products and services.
Company Info
| ISIN | CNE100000387 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Highlights
| Market Cap | HK$53.92B |
|---|---|
| EPS (TTM) | HK$2.37 |
| PE Ratio | 8.20 |
| PEG Ratio | 2.93 |
| Total Revenue (TTM) | HK$58.37B |
| Gross Profit (TTM) | HK$10.32B |
| Year Range | HK$16.62 - HK$23.29 |
| Target Price | HK$24.35 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in Guangzhou Baiyunshan Pharma, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Guangzhou Baiyunshan Pharma had a return of -1.58% year-to-date (YTD) and -5.07% in the last 12 months. Over the past 10 years, Guangzhou Baiyunshan Pharma had an annualized return of -0.21%, while the S&P 500 had an annualized return of 11.27%, indicating that Guangzhou Baiyunshan Pharma did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -1.58% | 19.68% |
| 1 month | 5.97% | 1.07% |
| 6 months | 10.91% | 9.66% |
| 1 year | -5.07% | 33.12% |
| 5 years (annualized) | -0.94% | 14.47% |
| 10 years (annualized) | -0.21% | 11.27% |
Monthly Returns
The table below presents the monthly returns of 0874.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -12.46% | 7.14% | -5.69% | 8.63% | 6.46% | -3.56% | -3.63% | -2.31% | -1.58% | ||||
| 2023 | -0.43% | 0.87% | 4.76% | 6.40% | 1.94% | -6.89% | -1.27% | -5.57% | 2.27% | -7.76% | 3.61% | 0.93% | -2.27% |
| 2022 | -11.54% | 4.98% | -0.48% | -1.69% | 7.35% | 8.92% | -9.78% | -8.82% | -10.36% | 3.18% | 19.14% | 10.31% | 6.25% |
| 2021 | 2.63% | 1.64% | -4.94% | 11.08% | 12.41% | 7.49% | -14.46% | -5.43% | -0.60% | -0.20% | -3.55% | 18.16% | 21.71% |
| 2020 | -5.26% | -5.56% | -12.19% | -1.91% | -8.10% | 3.82% | 23.72% | -13.80% | -4.73% | -5.07% | 8.82% | -4.80% | -26.53% |
| 2019 | 7.49% | 0.99% | 13.63% | 17.49% | -19.43% | 7.63% | -6.53% | -9.69% | -11.93% | -3.87% | -5.03% | 12.71% | -3.86% |
| 2018 | -0.87% | -7.00% | 13.88% | 25.21% | 35.31% | -15.61% | -2.14% | -13.47% | -3.46% | 2.33% | 10.68% | -11.23% | 23.36% |
| 2017 | -4.94% | 7.82% | 11.44% | -2.84% | -5.17% | 1.66% | -2.50% | -3.98% | 3.13% | 34.31% | -18.07% | 2.67% | 16.71% |
| 2016 | -21.91% | -5.48% | 8.15% | -5.94% | 6.92% | 3.86% | 5.03% | 2.71% | -3.55% | -3.68% | 3.63% | 7.45% | -6.96% |
| 2015 | 17.70% | -5.80% | 2.69% | 11.24% | 8.75% | -11.46% | -24.46% | -11.53% | 5.85% | 10.05% | -10.68% | 12.22% | -4.84% |
| 2014 | -6.89% | -0.60% | 4.99% | -12.17% | 3.68% | -5.22% | 10.59% | 8.87% | -1.48% | -0.38% | -11.32% | -0.21% | -12.29% |
| 2013 | 30.67% | 4.78% | 38.00% | -2.31% | 21.85% | -8.89% | 5.32% | -2.02% | 16.67% | -17.23% | 4.63% | -7.65% | 97.31% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 0874.HK is 31, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Guangzhou Baiyunshan Pharma (0874.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Guangzhou Baiyunshan Pharma granted a 3.99% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.82 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | HK$0.82 | HK$0.81 | HK$0.81 | HK$0.65 | HK$0.64 | HK$0.48 | HK$0.46 | HK$0.32 | HK$0.34 | HK$0.36 | HK$0.37 |
Dividend yield | 3.99% | 3.74% | 3.50% | 2.92% | 3.39% | 1.81% | 1.66% | 1.39% | 1.71% | 1.62% | 1.56% |
Monthly Dividends
The table displays the monthly dividend distributions for Guangzhou Baiyunshan Pharma. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.82 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.82 | |||
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.81 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.81 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.81 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.81 |
| 2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.65 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.65 |
| 2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.64 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.64 |
| 2019 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.48 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.48 |
| 2018 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.46 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.46 |
| 2017 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.32 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.32 |
| 2016 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.34 | HK$0.00 | HK$0.34 |
| 2015 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.36 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.36 |
| 2014 | HK$0.08 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.29 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.37 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Guangzhou Baiyunshan Pharma. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Guangzhou Baiyunshan Pharma was 56.84%, occurring on Mar 19, 2020. The portfolio has not yet recovered.
The current Guangzhou Baiyunshan Pharma drawdown is 41.33%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -56.84% | May 3, 2019 | 220 | Mar 19, 2020 | — | — | — |
| -56.42% | Oct 15, 2013 | 541 | Feb 12, 2016 | 553 | May 15, 2018 | 1094 |
| -43.93% | Jun 13, 2018 | 94 | Oct 29, 2018 | 123 | May 2, 2019 | 217 |
| -29.73% | Jul 16, 2012 | 92 | Dec 3, 2012 | 39 | Jan 30, 2013 | 131 |
| -21.12% | May 31, 2013 | 16 | Jun 24, 2013 | 65 | Sep 26, 2013 | 81 |
Volatility
Volatility Chart
The current Guangzhou Baiyunshan Pharma volatility is 12.45%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Guangzhou Baiyunshan Pharma compared to its peers in the Drug Manufacturers - Specialty & Generic industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for 0874.HK in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, 0874.HK has a PE value of 8.2. This PE value is considered to be low compared to the rest of the industry.
PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for 0874.HK in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, 0874.HK has a PEG value of 2.9. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Guangzhou Baiyunshan Pharma.
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |